Metacognitive training for schizophrenia: a systematic review

Jiangling Jiang, Li Zhang, Zhipei Zhu, Wei Li, Chunbo Li, Jiangling Jiang, Li Zhang, Zhipei Zhu, Wei Li, Chunbo Li

Abstract

Background: Metacognitive training (MCT) is a novel group psychotherapy method for schizophrenia, but there is, as yet, no conclusive evidence of its efficacy.

Aims: Conduct a meta-analysis to assess the effectiveness of MCT in schizophrenia.

Methods: Electronic and hand searches were conducted to identify randomized controlled trials about the effects of MCT in schizophrenia that met pre-defined inclusion criteria. The Cochrane Risk of Bias tool was employed to assess of risk of biases, and Cochrane Review Manager version 5.3 and R version 3.1.1 were used to conduct the data synthesis.

Results: Ten trials from 54 unduplicated reports were included in the review, but differences in the methods of assessing outcomes limited the number of studies that could be included in the meta-analysis. Pooling four studies that assessed the positive symptom subscale of the Positive and Negative Syndrome Scale (PANSS) at the end of the trial identified a small but statistically significant greater reduction in the MCT group than in the control group. But pooling four studies that assessed the delusion subscale of the Psychotic Symptom Rating Scales (PSYRATS) at the end of the trial found no significant difference between the groups. Results from the qualitative assessment of the other results that could not be pooled across studies were mixed, some showed a trend in favor of MCT but many found no difference between the groups.

Conclusions: The limited number of RCT trials, the variability of the method and time of the outcome evaluation, and methodological problems in the trials make it impossible to come to a conclusion about the effectiveness of MCT for schizophrenia. More randomized trials that use standardized outcome measures, that use intention-to-treat (ITT) analyses, and that follow-up participants at regular intervals after the intervention are needed to determine whether or not MCT should become a recommended adjunctive treatment for schizophrenia.

Keywords: meta-analysis; metacognitive training; randomized controlled trials; schizophrenia.

Figures

Figure 1.. Identification of included studies
Figure 1.. Identification of included studies
Figure 2.. Forest plot of positive symptom…
Figure 2.. Forest plot of positive symptom subscale score of the Positive and Negative Syndrome Scale (PANSS) assessed at the end of the intervention
Figure 3.. Forest plot of delusion subscale…
Figure 3.. Forest plot of delusion subscale score of the Psychotic Symptoms Rating Scales (PSYRATS) assessed at the end of the intervention
Figure 4.. Forest plot of the proportion…
Figure 4.. Forest plot of the proportion of enrolled participants who dropped out of the study

References

    1. World Health Organization[Internet] International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) version 2015. 2015. [cited 2015 June] Available from: .
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM V-5th edition) Virginia: American Psychiatric Publishing; 2013. pp. 97–327.
    1. World Health Organization. Report of the international pilot study of schizophrenia. Geneva: World Health Organization; 1973.
    1. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence prevalence and mortality. Epidemiologicreviews. 2008;30(1): 67–76. doi: 10.1093/epirev/mxn001.
    1. Drake RE, Bebout RR, Roach JP. A research evaluation of social network case management for homeless persons with dual disorders. In: Harris Maxine, Bergman Helen., editors. Case management for mentally ill patients: theory and practice. Switzerland: Harwood Academic Publishers; 1993. pp. 83–98.
    1. Mueser KT, McGurk SR. Schizophrenia. The Lancet. 2004;363(9426): 2063–2072. doi: 10.1016/S0140-6736(04)16458-1.
    1. van Os J, Kapur S. Schizophrenia. The Lancet. 2009;374(9690): 635–645. doi: 10.1016/S0140-6736(09)60995-8.
    1. Zink M, Englisch S, Meyer-Lindenberg A. [Polypharmacy in schizophrenia] Nervenarzt. 2011;82(7): 853–858 . German.
    1. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes clinical models and methodological rigor. Schizophr Bull. 2008;34(3): 523–537. doi: 10.1093/schbul/sbm114.
    1. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31(02): 189–195.
    1. Morrison AP. The interpretation of intrusions in psychosis: an integrative cognitive approach to hallucinations and delusions. Behav Cogn Psychother. 2001;29(03): 257–276.
    1. Freeman D. Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev. 2007;27(4): 425–457. doi: 10.1016/j.cpr.2006.10.004.
    1. Fine C, Gardner M, Craigie J, Gold I. Hopping, skipping or jumping to conclusions? Clarifying the role of the JTC bias in delusions. Cogn Neuropsychiatry. 2007;12(1): 46–77. doi: 10.1080/13546800600750597.
    1. Freeman D, Garety P, Kuipers E, Colbert S, Jolley S, Fowler D, et al. Delusions and decision-making style: use of the Need for Closure Scale. Behav Res Ther. 2006;44(8): 1147–1158. doi: 10.1016/j.brat.2005.09.002.
    1. Riccaboni R, Fresi F, Bosia M, Buonocore M, Leiba N, Smeraldi E, et al. Patterns of evidence integration in schizophrenia and delusion. Psychiatry Res. 2012;200(2): 108–114. doi: 10.1016/j.psychres.2012.04.005.
    1. Garety PA, Freeman D. Cognitive approaches to delusions: a critical review of theories and evidence. Br J Clin Psychol. 1999;38(2): 113–154.
    1. Bhatt R, Laws KR, McKenna PJ. False memory in schizophrenia patients with and without delusions. Psychiatry Res. 2010;178(2): 260–265. doi: 10.1016/j.psychres.2009.02.006.
    1. Moritz S, Woodward TS. Metacognitive training for schizophrenia patients (MCT): a pilot study on feasibility treatment adherence and subjective efficacy. German J Psychiatry. 2007;10(3): 69–78.
    1. Moritz S, Woodward TS. Metacognitive training in schizophrenia: from basic research to knowledge translation and intervention. Curr Opin Psychiatry. 2007;20(6): 619–625. doi: 10.1097/YCO.0b013e3282f0b8ed.
    1. Moritz S, Veckenstedt R, Randjbar S, Vitzthum F, Woodward TS. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improvesdelu sionals ymptoms . Psychol Med. 2011;41(09): 1823–1832. doi: 10.1017/S0033291710002618.
    1. Moritz S, Veckenstedt R, Bohn F, Hottenrott B, Scheu F, Randjbar S, et al. Complementary group Metacognitive Training (MCT) reducesdelu sionali deationin schizophrenia. Schizophre Res. 2013;151(1): 61–69. doi: 10.1016/j.schres.2013.10.007.
    1. Moritz S Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, et al. Sustained and “sleeper” effects of group metacognitive training for schizophrenia: a randomized clinical trial. JAMA Psychiatry. 2014;71(10): 1103–1111. doi: 10.1001/jamapsychiatry.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental DisordersDSM IV-4th edition. Virginia: American Psychiatric Publishing; 1995.
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) World Health Organization; 2015.
    1. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophre Bull. 1987;13(2): 261.
    1. Altman DG, Bland JM. Statistics Notes: Detecting skewness from summary information. BMJ. 1996;313(7066): 1200.
    1. Higgins JPT, Green S, editors. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 [Internet] 2009 Available from: .
    1. van Oosterhout B, Krabbendam L, de Boer K, Ferwerda J, van der Helm M, Stant AD, et al. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. Psychol Med. 2014;44(14): 3025–3035. doi: 10.1017/S0033291714000555.
    1. Favrod J, Rexhaj S, Bardy S, Ferrari P, Hayoz C, Moritz S, et al. Sustained antipsychotic effect of metacognitive training in psychosis: A randomized-controlled study. Eur Psychiatry. 2014;29(5): 275–281. doi: 10.1016/j.eurpsy.2013.08.003.
    1. Aghotor J, Pfueller U, Moritz S, Weisbrod M, Roesch-Ely D. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. J Behav Ther Exp Psychiatry. 2010;41(3): 207–211. doi: 10.1016/j.jbtep.2010.01.004.
    1. Lam KC, Ho CP, Wa JC, Chan SM, Yam KK, Yeung OS, et al. Metacognitive training (MCT) for schizophrenia improves cognitive insight: A randomized controlled trial in a Chinese sample with schizophrenia spectrum disorders. Behav Res Ther. 2015;64:38–42. doi: 10.1016/j.brat.2014.11.008.
    1. Briki M, Monnin J, Haffen E, Sechter D, Favrod J, Netillard C, et al. Metacognitive training for schizophrenia: A multicentrerandomised controlled trial. Schizophre Res. 2014;157(1): 99–106. doi: 10.1016/j.schres.2014.06.005.
    1. Kuokkanen R, Lappalainen R, Repo‐Tiihonen E, Tiihonen J. Metacognitive group training for forensic and dangerous non‐forensic patients with schizophrenia: A randomised controlled feasibility trial. Crim Behav Ment Health. 2014;24(5): 345–357. doi: 10.1002/cbm.1905.
    1. Moritz S, Kerstan A, Veckenstedt R, Randjbar S, Vitzthum F, Schmidt C, et al. Further evidence for the efficacy of a metacognitive group training in schizophrenia. Behav Res Ther. 2011;49(3): 151–157.. doi: 10.1016/j.brat.2010.11.010.
    1. Kumar D, Zia Ul, Haq M, Dubey I, Dotivala KN, Veqar Siddiqui S, et al. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur J Psychotherapy Counsel. 2010;12(2): 149–158.
    1. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS) Psychol Med. 1999;29(04): 879–889.
    1. National Institute for Health and Care Excellence 2014; c2014. National Institute for Health and Care Excellence. Schizophrenia (NICE clinical guidelines 178)[Internet] [Update February 2014; cited 2015 June] Available from: .
    1. Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, Rabb D. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(02): 138–144. doi: 10.1017/S0266462312000086.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere